|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03983 CHINA BLUECHEM
Nominal 
1.980 +0.030 (+1.538%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 12,989,832 | -9.029% | 14,279,054 | 13,398,008 | 10,417,493 | 10,858,435 |
| Cost of Sales | (10,928,762) | -6.929% | (11,742,407) | (10,461,599) | (9,083,765) | (8,937,079) |
| Gross Profit | 2,061,070 | -18.748% | 2,536,647 | 2,936,409 | 1,333,728 | 1,921,356 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 82,101 | 18.029% | 69,560 | (298,204) | -- | 43,638 | |
| Profit / (Loss) on Disposal | 858,229 | -- | -- | 590,846 | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 4,034 | -25.709% | 5,430 | 3,317 | 419 | (6,344) | |
| Profit / (Loss) before Taxation | 2,663,985 | 17.316% | 2,270,769 | 2,641,606 | 1,053,615 | 1,379,083 | |
| Taxation | (289,887) | -38.588% | (472,037) | (1,000,171) | (274,458) | (624,095) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 7,583 | -- | (156,154) | (143,837) | (33,672) | (51,771) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,381,681 | 44.997% | 1,642,578 | 1,497,598 | 745,485 | 703,217 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (314,132) | 6.562% | (294,788) | (322,512) | (183,438) | (127,547) |
| Depreciation & Amortisation | 627,514 | 10.706% | 566,827 | 557,739 | 648,251 | 703,030 |
| Directors' Emoluments | 1,898 | -45.129% | 3,459 | 4,520 | 2,570 | 3,260 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 52.000 | 44.444% | 36.000 | 32.000 | 16.000 | 15.000 |
| DPS (cts) | 20.700 | -- | 17.800 | 15.500 | 8.000 | 7.600 |
| Dividend Payout Ratio (%) | 39.808% | -- | 49.444% | 48.438% | 50.000% | 50.667% |
| Cash flow per share ($) | 0.335 | -- | 0.465 | 0.637 | 0.274 | 0.248 |
| NBV per share ($) | 3.970 | -- | 3.633 | 3.433 | 3.189 | 3.104 |
| Remarks: | Real time quote last updated: 27/11/2024 17:19 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 686,827 |
| %Change | -59.961% |
| EPS / (LPS) | RMB 0.150 |
| NBV Per Share (¥) | RMB 3.911 |